Holen Sie sich die Stockscreener-App
36.00
5.22%
1.69
Schlusskurs vom Vortag:
$34.31
Offen:
$34.92
24-Stunden-Volumen:
1.38M
Relative Volume:
0.60
Marktkapitalisierung:
$5.48B
Einnahmen:
$3.44B
Nettoeinkommen (Verlust:
$-8.30M
KGV:
-242.10
EPS:
-0.1487
Netto-Cashflow:
$43.30M
1W Leistung:
+0.81%
1M Leistung:
-9.99%
6M Leistung:
+11.12%
1J Leistung:
-13.51%
1-Tages-Spanne:
$34.66
$36.45
1-Wochen-Bereich:
$33.11
$37.00
52-Wochen-Spanne:
$28.53
$56.22
Bruker Corp Stock (BRKR) Company Profile
Firmenname
Bruker Corp
Sektor
Branche
Telefon
978663-3660
Adresse
40 MANNING RD, BILLERICA, MA
Compare BRKR vs ABT, SYK, MDT, BSX, EW
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
BRKR
Bruker Corp
|
36.02 | 5.22B | 3.44B | -8.30M | 43.30M | -0.1487 |
ABT
Abbott Laboratories
|
102.35 | 177.03B | 44.33B | 6.50B | 7.40B | 3.717 |
SYK
Stryker Corp
|
327.89 | 124.89B | 25.12B | 3.25B | 4.28B | 8.3984 |
MDT
Medtronic Plc
|
86.51 | 110.08B | 35.48B | 4.64B | 5.41B | 3.582 |
BSX
Boston Scientific Corp
|
62.32 | 93.53B | 20.08B | 2.89B | 3.66B | 1.9391 |
EW
Edwards Lifesciences Corp
|
79.86 | 45.84B | 6.07B | 1.06B | 1.34B | 1.8063 |
Bruker Corp Stock (BRKR) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-12-10 | Hochstufung | Wolfe Research | Peer Perform → Outperform |
| 2025-12-09 | Eingeleitet | Goldman | Sell |
| 2025-11-20 | Eingeleitet | Rothschild & Co Redburn | Buy |
| 2025-05-22 | Herabstufung | Citigroup | Buy → Neutral |
| 2024-12-19 | Eingeleitet | Guggenheim | Buy |
| 2024-12-10 | Eingeleitet | UBS | Neutral |
| 2024-12-05 | Hochstufung | Goldman | Sell → Neutral |
| 2024-10-15 | Eingeleitet | Barclays | Overweight |
| 2024-09-30 | Herabstufung | Wolfe Research | Outperform → Peer Perform |
| 2024-08-28 | Eingeleitet | Wells Fargo | Overweight |
| 2024-06-03 | Fortgesetzt | Jefferies | Buy |
| 2024-02-14 | Hochstufung | JP Morgan | Neutral → Overweight |
| 2023-12-19 | Eingeleitet | Wells Fargo | Equal Weight |
| 2023-12-13 | Eingeleitet | Wolfe Research | Outperform |
| 2022-10-21 | Eingeleitet | UBS | Buy |
| 2022-08-22 | Hochstufung | Citigroup | Neutral → Buy |
| 2021-10-15 | Fortgesetzt | Cowen | Market Perform |
| 2021-06-15 | Hochstufung | Cleveland Research | Neutral → Buy |
| 2021-02-05 | Herabstufung | Wells Fargo | Overweight → Equal Weight |
| 2020-12-02 | Eingeleitet | Goldman | Sell |
| 2020-11-16 | Hochstufung | Wolfe Research | Underperform → Peer Perform |
| 2020-05-01 | Herabstufung | Cleveland Research | Buy → Neutral |
| 2020-04-02 | Herabstufung | Wolfe Research | Peer Perform → Underperform |
| 2020-04-01 | Herabstufung | Needham | Strong Buy → Hold |
| 2020-03-26 | Hochstufung | Barclays | Equal Weight → Overweight |
| 2020-01-08 | Eingeleitet | Wells Fargo | Overweight |
| 2020-01-07 | Eingeleitet | Citigroup | Buy |
| 2019-11-15 | Eingeleitet | Stifel | Hold |
| 2019-09-26 | Hochstufung | BofA/Merrill | Neutral → Buy |
| 2019-07-15 | Hochstufung | Goldman | Sell → Neutral |
| 2019-06-24 | Bestätigt | Needham | Strong Buy |
| 2019-06-21 | Bestätigt | BofA/Merrill | Neutral |
| 2019-05-30 | Eingeleitet | Wolfe Research | Peer Perform |
| 2019-05-06 | Bestätigt | Needham | Strong Buy |
| 2019-05-03 | Hochstufung | SVB Leerink | Mkt Perform → Outperform |
| 2019-05-03 | Hochstufung | UBS | Sell → Neutral |
| 2019-04-12 | Hochstufung | Deutsche Bank | Hold → Buy |
| 2019-02-12 | Bestätigt | BTIG Research | Buy |
| 2019-01-03 | Eingeleitet | Needham | Strong Buy |
Alle ansehen
Bruker Corp Aktie (BRKR) Neueste Nachrichten
Bruker Corp (BRKR) Shares Up 3.62% on Mar 30 - GuruFocus
Bruker Corp (BRKR) Stock Price Quote Today & Current Price Chart - Capital.com
Guggenheim Lowers Bruker (BRKR) Price Target to $50 with Maintai - GuruFocus
Bruker (BRKR) Subsidiaries Impacted by Patent Trial Outcome - GuruFocus
JPMorgan Chase & Co. Trims Stock Position in Bruker Corporation $BRKR - MarketBeat
CONMED, Bruker, Waters Corporation, Avantor, and Bio-Techne Stocks Trade Down, What You Need To Know - Yahoo Finance
Vanguard disaggregates holdings; reports 0 shares in Bruker (NYSE: BRKR) - Stock Titan
Bruker introduces analytical and automation innovations at analytica 2026 - selectscience.net
Bruker (BRKR) Stock Is Up, What You Need To Know - Yahoo Finance
Here’s Why Bruker’s (BRKR) Positive Momentum Returned in Q4 - Yahoo Finance
Bruker Corporation (NASDAQ:BRKR) Declares Quarterly Dividend of $0.05 - MarketBeat
Assessing Bruker (BRKR) Valuation After Steep Multi‑Period Share Price Declines - Yahoo Finance
Will Bruker (BRKR) be Able to Rebound? - Insider Monkey
Bruker (NASDAQ: BRKR) EVP Mark Munch exercises options and sells 2,000 shares - Stock Titan
Bruker Corporation $BRKR Shares Purchased by Aquatic Capital Management LLC - MarketBeat
Bruker Corp Stock (ISIN: US1167941087) Faces Rising Short Interest Amid Investor Scrutiny - AD HOC NEWS
Callodine Capital Management LP Makes New $1.11 Million Investment in Bruker Corporation $BRKR - MarketBeat
Mark R Munch reports multiple share sales (BRKR) under Rule 144 - Stock Titan
Bruker Corp (BRKR) Trading Down 3.62% on Mar 13 - GuruFocus
Bruker Corp. Experiences Revision in Stock Evaluation Amid Market Dynamics and Performance Challenges - Markets Mojo
Bruker Makes Acquisitions; LeddarTech Added to Nasdaq: Week in Brief: 1/5/24 - Photonics Spectra
Natixis Advisors LLC Boosts Stock Position in Bruker Corporation $BRKR - MarketBeat
Bruker Corporation $BRKR Position Increased by Ceredex Value Advisors LLC - MarketBeat
Is Bruker (BRKR) Quietly Recasting Its Competitive Moat With Spatial Biology And Proteomics Upgrades? - simplywall.st
These analysts cut their forecasts on Bruker following Q4 results - MSN
Citigroup Inc. Sells 29,083 Shares of Bruker Corporation $BRKR - MarketBeat
Bruker Corporation $BRKR Shares Acquired by Rhenman & Partners Asset Management AB - MarketBeat
Bio-Techne, Bruker, DexCom, STERIS, and Teleflex Shares Plummet, What You Need To Know - Finviz
RSI Alert: Bruker (BRKR) Now Oversold - Nasdaq
Orbis group reports 16.13M shares in Bruker (BRKR) as 10.6% ownership - Stock Titan
Research Tools & Consumables Stocks Q4 In Review: Bruker (NASDAQ:BRKR) Vs Peers - Yahoo Finance
Bruker Corp To Go Ex-Dividend On March 23rd, 2026 With 0.05 USD Dividend Per Share - 富途牛牛
BRKRP Financials: Income Statement, Balance Sheet & Cash Flow - Stock Titan
BRKR Financials: Income Statement, Balance Sheet & Cash Flow - Stock Titan
BofA Securities Maintains Bruker Corp(BRKR.US) With Buy Rating, Maintains Target Price $49 - 富途牛牛
Artisan Partners Limited Partnership Invests $13.69 Million in Bruker Corporation $BRKR - MarketBeat
Bruker Corp. Experiences Revision in Stock Evaluation Amid Market Volatility - Markets Mojo
Assessing Bruker (BRKR) Valuation After New Spatial Biology Platforms And Collaboration Updates - simplywall.st
BRKR PE Ratio & Valuation, Is BRKR Overvalued - Intellectia AI
Beyond the Balance Sheet: What SWOT Reveals About Bruker Corp (B - GuruFocus
Bruker (NASDAQ: BRKR) outlines 2025 business segments, risks and $2.57B backlog - Stock Titan
Bruker (BRKR): Buy, Sell, or Hold Post Q4 Earnings? - Yahoo Finance
Bruker Accelerates the Future of Diagnostic and Prognostic Spatial Proteomics With the Launch of CellScape XR - 富途牛牛
Is Bruker (BRKR) Now Offering Value After A Prolonged Share Price Slump? - Yahoo Finance
Bruker Corporation (NASDAQ:BRKR) Given Average Rating of "Hold" by Brokerages - MarketBeat
New Bruker tool targets 3,000-patient tumor study in spatial proteomics - Stock Titan
Reasons Why Bruker Corporation (BRKR) Appears So Attractive - Finviz
Inside Bruker and Noetik’s push toward 1B mapped human cells - Stock Titan
Bruker unveils spatial biology platforms at AGBT conference - Investing.com
Bruker unveils spatial biology platforms at AGBT conference By Investing.com - Investing.com Canada
Finanzdaten der Bruker Corp-Aktie (BRKR)
Umsatz
Nettogewinn
Free Cashflow
ENV
Bruker Corp-Aktie (BRKR) Insiderhandel
| Insiderhandel | Beziehung | Datum | Transaktion | Kosten | #Aktien | Wert ($) | #Aktien Gesamt |
|---|---|---|---|---|---|---|---|
| Munch Mark | EXEC VP&PRES BRUKER NANO INC. |
Mar 13 '26 |
Sale |
35.44 |
2,000 |
70,880 |
128,443 |
2.00%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):